Evaluation of pembrolizumab plus cisplatin and fluorouracil in radical treatment for patients with T4b esophageal squamous cell carcinoma.
Hokamura N, Fukagawa T, Fukushima R, Kiyokawa T, Horikawa M, Soeda N, Suzuki Y, Kaneshiro S, Abe K, Kodashima S, Yamamoto T, Oshima Y, Ishida T, Sasajima Y, Nomoto A, Shiraishi K, Ito A.
Hokamura N, et al. Among authors: sasajima y.
BMC Gastroenterol. 2024 Sep 2;24(1):295. doi: 10.1186/s12876-024-03382-w.
BMC Gastroenterol. 2024.
PMID: 39223478
Free PMC article.